Skip to main content
Commonwealth of Virginia branding bar cardinal logo

Virginia.gov

A design prototype by Datopian, not an official website

Find a Commonwealth Resource

Somapacitan-beco

HealthData.Gov

Updated Oct 29, 2026

About this dataset

Sogroya (generic: somapacitan-beco) is a prescription injection solution made by Novo Nordisk for subcutaneous use. It contains somapacitan at 3.3 mg/mL strength and was approved under BLA761156, with marketing starting in May 2023. This information was generated using AI and is provided for informational and research purposes only.

Data and resources (1)

  • HTML

    Somapacitan-beco

    Access the FDA dataset for Somapacitan-beco — ANDA 761156 submitted by Mylan Institutional LLC

    Modified Apr 29, 2026

Prototype by Datopian · not an official government website · data from data.virginia.gov